BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 32745509)

  • 1. Danlou tablet inhibits the inflammatory reaction of high-fat diet-induced atherosclerosis in ApoE knockout mice with myocardial ischemia via the NF-κB signaling pathway.
    Gao S; Xue X; Yin J; Gao L; Li Z; Li L; Gao S; Wang S; Liang R; Xu Y; Yu C; Zhu Y
    J Ethnopharmacol; 2020 Dec; 263():113158. PubMed ID: 32745509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethanol extracts of Danlou tablet attenuate atherosclerosis via inhibiting inflammation and promoting lipid effluent.
    Hao D; Danbin W; Maojuan G; Chun S; Bin L; Lin Y; Yingxin S; Guanwei F; Yefei C; Qing G; Xijuan J
    Pharmacol Res; 2019 Aug; 146():104306. PubMed ID: 31181336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZeXieYin formula alleviates atherosclerosis by inhibiting the MAPK/NF-κB signaling pathway in APOE-/- mice to attenuate vascular inflammation and increase plaque stability.
    Huang R; Sun Y; Liu R; Zhu B; Zhang H; Wu H
    J Ethnopharmacol; 2024 Jun; 327():117969. PubMed ID: 38437888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibition of endothelial NF-κB signaling attenuates chronic intermittent hypoxia-induced atherosclerosis in mice.
    Song D; Fang G; Mao SZ; Ye X; Liu G; Miller EJ; Greenberg H; Liu SF
    Atherosclerosis; 2018 Mar; 270():68-75. PubMed ID: 29407890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Shoushen granule on adenosine triphosphate binding cassette transporter A1, proprotein convertase subtilisin/kexin type 9 and toll-like receptor 4/nuclear factor kappa-B signaling pathway in ApoE-knockout mice.
    Li S; Cao H; Shen D; Chen C; Xing S; Dou F; Jia Q
    J Tradit Chin Med; 2019 Aug; 39(4):524-534. PubMed ID: 32186100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of phospholipid peroxidation signaling by a traditional Chinese medicine formula for coronary heart disease.
    Ma X; Wang Q; Liu C; Liu J; Luo G; He L; Yuan T; He RR; Yao Z
    Phytomedicine; 2023 Jun; 114():154749. PubMed ID: 36931097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLR4/NF-κB signaling contributes to chronic unpredictable mild stress-induced atherosclerosis in ApoE-/- mice.
    Tang YL; Jiang JH; Wang S; Liu Z; Tang XQ; Peng J; Yang YZ; Gu HF
    PLoS One; 2015; 10(4):e0123685. PubMed ID: 25860573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cinnamaldehyde attenuates atherosclerosis via targeting the IκB/NF-κB signaling pathway in high fat diet-induced ApoE
    Li W; Zhi W; Zhao J; Li W; Zang L; Liu F; Niu X
    Food Funct; 2019 Jul; 10(7):4001-4009. PubMed ID: 31210194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pterostilbene, a novel natural plant conduct, inhibits high fat-induced atherosclerosis inflammation via NF-κB signaling pathway in Toll-like receptor 5 (TLR5) deficient mice.
    Zhang Y; Zhang Y
    Biomed Pharmacother; 2016 Jul; 81():345-355. PubMed ID: 27261612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Danlou Tablet Improves Chronic Intermittent Hypoxia-Induced Dyslipidemia and Arteriosclerosis by HIF-1α-Angptl4 mRNA Signaling Pathway.
    Tang JJ; Li GX; Liu ZG; Yi R; Yu D; Zhang YB; Zhao SQ; Wang SH
    Chin J Integr Med; 2022 Jun; 28(6):509-517. PubMed ID: 32623702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guanxinping ameliorates atherosclerosis via MAPK/NF-κB signaling pathway in ApoE
    Zhang S; Zhang S; Liang X; Huang Y; Tang L; Liu F; Xu X; Ye F; Liu J; Liu J; Yan S; Han X
    Perfusion; 2023 Apr; 38(3):557-566. PubMed ID: 35102779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of tanshinone IIA and astragaloside IV attenuate atherosclerotic plaque vulnerability in ApoE(-/-) mice by activating PI3K/AKT signaling and suppressing TRL4/NF-κB signaling.
    Wang N; Zhang X; Ma Z; Niu J; Ma S; Wenjie W; Chen J
    Biomed Pharmacother; 2020 Mar; 123():109729. PubMed ID: 31887543
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Wu R; Zhang L; Xu H; Chen H; Zhao W; Zhou Y; Zhou L; Wu J; An S
    Cardiovasc Hematol Agents Med Chem; 2023; 21(3):232-239. PubMed ID: 36748219
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Karunakaran D; Nguyen MA; Geoffrion M; Vreeken D; Lister Z; Cheng HS; Otte N; Essebier P; Wyatt H; Kandiah JW; Jung R; Alenghat FJ; Mompeon A; Lee R; Pan C; Gordon E; Rasheed A; Lusis AJ; Liu P; Matic LP; Hedin U; Fish JE; Guo L; Kolodgie F; Virmani R; van Gils JM; Rayner KJ
    Circulation; 2021 Jan; 143(2):163-177. PubMed ID: 33222501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microrna-145 accelerates the inflammatory reaction through activation of NF-κB signaling in atherosclerosis cells and mice.
    Li S; Sun W; Zheng H; Tian F
    Biomed Pharmacother; 2018 Jul; 103():851-857. PubMed ID: 29710501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Jiangzhi Xiaoban tablet on toll-like receptor 4/nuclear factor-kappa B/nod-like receptor protein 3 signaling pathway in mice with atherosclerosis induced by high-fat diet.
    Huihui L; Jun F; Jianhe L; Choufu C; Guoheng HU
    J Tradit Chin Med; 2024 Feb; 44(1):88-94. PubMed ID: 38213243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway.
    Tang ZH; Peng J; Ren Z; Yang J; Li TT; Li TH; Wang Z; Wei DH; Liu LS; Zheng XL; Jiang ZS
    Atherosclerosis; 2017 Jul; 262():113-122. PubMed ID: 28535426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peperomin E (PepE) protects against high fat diet-induced atherosclerosis in Apolipoprotein E deficient (ApoE
    Yan J; Li M; Wang XD; Lu ZY; Ni XL
    Biomed Pharmacother; 2018 Sep; 105():862-869. PubMed ID: 30021379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective Effect of Panax Notoginseng Saponins on Apolipoprotein-E-deficient Atherosclerosis-prone Mice.
    Yang H; Liu Z; Hu X; Liu X; Gui L; Cai Z; Dai C
    Curr Pharm Des; 2022; 28(8):671-677. PubMed ID: 35088656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dan-Lou tablets reduce inflammatory response by inhibiting the activation of NLRP3 inflammasome for coronary heart disease.
    Gao S; He Y; Liu Y; Yu L; Cheng Q; Wang S; Li L; Cui Y; Yu C; Li Z
    Phytomedicine; 2024 Aug; 131():155773. PubMed ID: 38833946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.